Structure-based design of potent aromatase inhibitors by high-throughput docking

Journal of Medicinal Chemistry

Volumn 54, Issue 12, 2011, Pages 4006-4017

  Caporuscio, Fabiana ^a   Rastelli, Giulio ^a   Imbriano, Carol ^a   Del Rio, Alberto ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AOP 13801200; AOP 13848083; AROMATASE INHIBITOR; BAS 00665638; BAS 00782664; BAS 02077837; BAS 05399144; BAS 11404029; BAS 11404034; BAS 12378719; BAS 12756136; BAS 12914183; BAS 12914671; BAS 12914683; BAS 12927218; BAS 15369430; LEG 13848093; LEG 21508414; LEG 22473243; SYN 15645644; SYN 15645717; SYN 17475691; SYN 19577078; SYN 19990642; SYN 19994888; SYN 19999063; SYN 20028567; SYN 22987768; SYN 23725844; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; DRUG DESIGN; DRUG STRUCTURE; HIGH THROUGHPUT SCREENING; MOLECULAR DOCKING; STRUCTURE ACTIVITY RELATION;

AROMATASE; AROMATASE INHIBITORS; BINDING SITES; CACO-2 CELLS; DRUG DESIGN; HUMANS; IMIDAZOLES; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PERMEABILITY; PROTEIN BINDING; SMALL MOLECULE LIBRARIES; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 79959410458     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm2000689     Document Type: Article

References (47)

1. Macedo, L. F.; Sabnis, G.; Brodie, A. Aromatase inhibitors and breast cancer Ann. N. Y. Acad. Sci. 2009, 1155, 162-173
2. Hong, Y.; Chen, S. Aromatase inhibitors: structural features and biochemical characterization Ann. N.Y. Acad. Sci. 2006, 1089, 237-251 (Pubitemid 47092077)
3. Dutta, U.; Pant, K. Aromatase inhibitors: past, present and future in breast cancer therapy Med. Oncol. 2008, 25, 113-124
4. Ghosh, D.; Griswold, J.; Erman, M.; Pangborn, W. Structural basis for androgen specificity and oestrogen synthesis in human aromatase Nature 2009, 457, 219-223
5. Schuster, D.; Laggner, C.; Steindl, T. M.; Palusczak, A.; Hartmann, R. W.; Langer, T. Pharmacophore modeling and in silico screening for new P450 19 (aromatase) inhibitors J. Chem. Inf. Model. 2006, 46, 1301-1311 (Pubitemid 43999173)
6. Neves, M. A.; Dinis, T. C.; Colombo, G.; Sá e Melo, M. L. Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors J. Med. Chem. 2009, 52, 143-150
7. Neves, M. A.; Dinis, T. C.; Colombo, G.; Sá e Melo, M. L. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors Eur. J. Med. Chem. 2009, 44, 4121-4127
8. Gobbi, S.; Cavalli, A.; Negri, M.; Schewe, K. E.; Belluti, F.; Piazzi, L.; Hartmann, R. W.; Recanatini, M.; Bisi, A. Imidazolylmethylbenzophenones as highly potent aromatase inhibitors J. Med. Chem. 2007, 50, 3420-3422 (Pubitemid 47195449)
9. Jackson, T.; Woo, L. W.; Trusselle, M. N.; Purohit, A.; Reed, M. J.; Potter, B. V. L. Non-steroidal aromatase inhibitors based on a biphenyl scaffold: synthesis, in vitro SAR, and molecular modelling ChemMedChem 2008, 3) 603-618
10. Alvarez, J. C. High-throughput docking as a source of novel drug leads Curr. Opin. Chem. Biol. 2004, 8, 365-370 (Pubitemid 38993729)
11. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug. Delivery Rev. 1997, 23, 3-25 (Pubitemid 27046991)
12. Favia, A. D.; Cavalli, A.; Masetti, M.; Carotti, A.; Recanatini, M. Three-dimensional model of the human aromatase enzyme and density functional parameterization of the iron-containing protoporphyrin IX for a molecular dynamics study of heme-cysteinato cytochromes Proteins 2006, 62, 1074-1087 (Pubitemid 43364170)
13. Karkola, S.; Höltje, H. D.; Wähälä, K. J. A three-dimensional model of CYP19 aromatase for structure-based drug design Steroid Biochem. Mol. Biol. 2007, 105, 63-70 (Pubitemid 47211957)
14. Steindl, T.; Langer, T. Docking versus pharmacophore model generation: a comparison of high-throughput virtual screening strategies for the search of human rhinovirus coat protein inhibitors QSAR Comb. Sci. 2005, 24, 470-479 (Pubitemid 40846439)
15. Röhrig, U. F.; Grosdidier, A.; Zoete, V.; Michielin, O. Docking to heme proteins J. Comput. Chem. 2009, 3, 2305-2315
16. Schrödinger; Schrödinger LLC: New York, 2005; http://www.schrodinger.com.
17. Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy J. Med. Chem. 2004, 47, 1739-1749 (Pubitemid 38380917)
18. Eldridge, M. D.; Murray, C. W.; Auton, T. R.; Paolini, G. V.; Mee, R. P. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes J. Comput.-Aided Mol. Des. 1997, 11, 425-445 (Pubitemid 127505895)
19. Chen, X.; Liu, M.; Gilson, M. K. Binding DB: a web-accessible molecular recognition database. Comb. Chem. High Throughput Screening 2001, 4, 719-725; http://www.bindingdb.org (accessed May 5, 2009). (Pubitemid 34003162)
20. Friesner, R. A.; Murphy, R. B.; Repasky, M. P.; Frye, L. L.; Greenwood, J. R.; Halgren, T. A.; Sanschagrin, P. C.; Mainz, D. T. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes J. Med. Chem. 2006, 49, 6177-6196 (Pubitemid 44595196)
21. Verras, A.; Kuntz, I. D.; Ortiz de Montellano, P. R. Computer-assisted design of selective imidazole inhibitors for cytochrome p450 enzymes J. Med. Chem. 2004, 47, 3572-3579 (Pubitemid 38822018)
22. Woo, L. W. L.; Bubert, C.; Sutcliffe, O. B.; Smith, A.; Chander, S. K.; Mahon, M. F.; Purohit, A.; Reed, M. J.; Potter, B. V. L. Dual aromatase-steroid sulfatase inhibitors J. Med. Chem. 2007, 50, 3540-3560 (Pubitemid 47195462)
23. Ewing, T. J.; Makino, S.; Skillman, A. G.; Kuntz, I. D. DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases J. Comput.-Aided Mol. Des. 2001, 15, 411-428 (Pubitemid 32452109)
24. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking J. Mol. Biol. 1997, 267, 727-748 (Pubitemid 27170693)
25. Asinex; Asinex Ltd: Moscow; http://www.asinex.com.
26. Testa, B.; Jenner, P. Inhibitors of cytochrome P-450s and their mechanism of action Drug Metab. Rev. 1981, 12, 1-117 (Pubitemid 12208842)
27. Balding, P. R.; Porro, C. S.; McLean, K. J.; Sutcliffe, M. J.; Maréchal, J. D.; Munro, A. W.; de Visser, S. P. How do azoles inhibit cytochrome P450 enzymes? A density functional study J. Phys. Chem. A 2008, 112, 12911-12918
28. Hartmann, R. W.; Bayer, H.; Grün, G.; Sergejew, T.; Bartz, U.; Mitrenga, M. Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom J. Med. Chem. 1995, 38, 2103-2111
29. Rogerson, T. D.; Wilkinson, C. F.; Hetarski, K. Steric factors in the inhibitory interaction of imidazoles with microsomal enzymes Biochem. Pharmacol. 1977, 26, 1039-1042 (Pubitemid 8107444)
30. Veber, D. F.; Johnson, S. R.; Cheng, H. Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. Molecular properties that influence the oral bioavailability of drug candidates J. Med. Chem. 2002, 45, 2615-2623 (Pubitemid 34595232)
31. Jacobsson, M.; Gäredal, M.; Schultz, J.; Karlén, A. Identification of Plasmodium falciparum spermidine synthase active site binders through structure-based virtual screening J. Med. Chem. 2008, 51, 2777-2786 (Pubitemid 351620799)
32. Stresser, D. M.; Turner, S. D.; McNamara, J.; Stocker, P.; Miller, V. P.; Crespi, C. L.; Patten, C. J. A high-throughput screen to identify inhibitors of aromatase (CYP19) Anal. Biochem. 2000, 284, 427-430
33. Zhao, Y.; White, M. A.; Muralidhara, B. K.; Sun, L.; Halpert, J. R.; Stout, C. D. Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction J. Biol. Chem. 2006, 281, 5973-5981 (Pubitemid 43847698)
34. Sherman, W.; Day, T.; Jacobson, M. P.; Friesner, R. A.; Farid, R. Novel procedure for modeling ligand/receptor induced fit effects J. Med. Chem. 2006, 49, 534-553 (Pubitemid 43157487)
35. Kao, Y. C.; Korzekwa, K. R.; Laughton, C. A.; Chen, S. Evaluation of the mechanism of aromatase cytochrome P450. A site-directed mutagenesis study Eur. J. Biochem. 2001, 268, 243-251 (Pubitemid 32867307)
36. Kao, Y. C.; Cam, L. L.; Laughton, C. A.; Zhou, D.; Chen, S. Binding characteristics of seven inhibitors of human aromatase: a site-directed mutagenesis study Cancer Res. 1996, 56, 3451-3460 (Pubitemid 26251636)
37. Hoon, S.; Smith, A. M.; Wallace, I. M.; Suresh, S.; Miranda, M.; Fung, E.; Proctor, M.; Shokat, K. M.; Zhang, C.; Davis, R. W.; Giaever, G.; St Onge, R. P.; Nislow, C. An integrated platform of genomic assays reveals small-molecule bioactivities Nature Chem. Biol. 2008, 4, 498-506
38. La Regina, G.; DAuria, F. D.; Tafi, A.; Piscitelli, F.; Olla, S.; Caporuscio, F.; Nencioni, L.; Cirilli, R.; La Torre, F.; De Melo, N. R.; Kelly, S. L.; Lamb, D. C.; Artico, M.; Botta, M.; Palamara, A. T.; Silvestri, R. 1-[(3-Aryloxy-3-aryl)propyl]-1 H -imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies J. Med. Chem. 2008, 51, 3841-3855 (Pubitemid 351956514)
39. Poulos, T. L.; Howard, A. J. Crystal structures of metyrapone- and phenylimidazole-inhibited complexes of cytochrome P-450cam Biochemistry 1987, 26, 8165-8174 (Pubitemid 18023065)
40. RDKit: Cheminformatics and Machine Learning Software; Sourceforge; http://www.rdkit.org.
41. Wood, P. M.; Woo, L. W.; Labrosse, J. R.; Thomas, M. P.; Mahon, M. F.; Chander, S. K.; Purohit, A.; Reed, M. J.; Potter, B. V. L. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4- cyanophenyl)(4 H -1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities ChemMedChem. 2010, 5) 1577-1593
42. Sun, B.; Hoshino, J.; Jermihov, K.; Marler, L.; Pezzuto, J. M.; Mesecar, A. D.; Cushman, M. Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer Bioorg. Med. Chem. 2010, 18, 5352-5366
43. Ravindranathan, K. P.; Mandiyan, V.; Ekkati, A. R.; Bae, J. H.; Schlessinger, J.; Jorgensen, W. L. Discovery of novel fibroblast growth factor receptor 1 kinase inhibitors by structure-based virtual screening J. Med. Chem. 2010, 53, 1662-1672
44. Del Rio, A.; Barbosa, A. J.; Caporuscio, F.; Mangiatordi, G. F. CoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposes. Mol. Biosyst. 2010, 6, 2122-2128; http://www.cococo-database.it (release 2010).
45. Molecular Networks: Inspiring Chemical Discovery; Molecular Networks GmbH-Computerchemie, Erlangen, Germany; http://www.molecular-networks.com.
46. Gasteiger, J.; Rudolph, C.; Sadowski, J. Automatic generation of 3D-atomic coordinates for organic molecules Tetrahedron Comput. Methods 1990, 3, 537-547
47. GraphPad Software; GraphPad Software: San Diego, CA; www.graphpad.com.